Description
Publication/Article
Safety Profile of Combined Same-Day Treatment for Botulinum Toxin With Full Face Nonablative Fractionated Laser Resurfacing
Citation: Pomerantz H, Akintilo L, Shaw K, Lederhandler M, Anolik R, Geronemus RG. Safety Profile of Combined Same-Day Treatment for Botulinum Toxin With Full Face Nonablative Fractionated Laser Resurfacing. Dermatol Surg. 2021 Apr 1;47(4):500-503.
Description
This webinar will review the findings published from a retrospective study to assess the frequency of eyelid ptosis after the glabella/periorbital botulinum toxin injection. The session will start with a summary of the key findings from publication, followed by an expert panel discussion of the publication.
Learning Objectives
Following this activity, participants should be able to:
- Summarize objective, methods and results of a retrospective study.
- Assess the potential significance of a retrospective-based study and published findings for dermatologic surgeons.
- Discuss the risk of spread of glabella/periorbital botulinum toxin to an unintended muscle.
CME: 1.00 AMA PRA Category 1 Credit™
To obtain CME credit in your ASDS Learn profile and download your CME certificate, you will need to view the webinar and complete the attendee evaluation. Credit is provided for live webinar attendees.
Accreditation Statement
The American Society for Dermatologic Surgery (ASDS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. ASDS designates this activity for a maximum of 1.00AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
About Disclosures: View Here